Growing up in the San Gabriel Valley as a first-generation immigrant, I had always heard wonderful things about City of Hope and its work in the community. As a physician, I am excited to join the team and take care of remarkable women by providing compassionate, personalized care with clinical excellence.

Jeff F. Lin, M.D., is passionate about bringing the leading edge of gynecologic oncology to his patients while delivering personalized care. As a gynecologic oncologist, he is honored to have joined a multidisciplinary team of experts focused on providing compassionate, whole-patient care with clinical excellence. Double board-certified in gynecologic oncology and obstetrics and gynecology, Dr. Lin brings years of experience to City of Hope | South Bay.

Dr. Lin received his medical degree from Chicago’s Northwestern University and continued his training at New York-Presbyterian Hospital-Cornell, Memorial Sloan Kettering Cancer Center in New York, and Magee-Womens Hospital in Pittsburgh.

Dr. Lin is well-versed in all forms of women’s cancers and has specialized training in laparoscopic and robotic surgery, as well as HIPEC (hyperthermic intraperitoneal chemotherapy). In addition to his work with patients, Dr. Lin’s research is focused on novel surgical techniques and improving patient outcomes. Southern California is home for Dr. Lin, and he is excited to be a part of the City of Hope family.

Location

South Bay

5215 Torrance Boulevard
Torrance, CA 90503

Phone Numbers

Education & Experience

Degrees

2007, Doctor of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL
2003, Bachelor of Arts, Northwestern University, Evanston, IL

Fellowship

2011-2014, Fellow, Gynecologic Oncology, Magee-Women’s Hospital/University of Pittsburgh, Pittsburgh, PA

Residency

2011-2014, Resident, Obstetrics and Gynecology, New York Presbyterian Weill Cornell Medical Center, New York, NY
2009, Galloway Rotating Resident Program, Surgery/Gynecology, Memorial Sloan-Kettering Cancer Center, New York, NY

Professional Experience

2021-present, Assistant Clinical Professor, Division of Gynecologic Oncology, Department of Surgery, City of Hope, Torrance, CA
2016-2020, Medical Director, Gynecologic Oncology, Washington Hospital Healthcare System, Fremont, CA
2014-2020, Gynecologic Oncologist, Private Practice, Bay Area Gynecology Oncology, San Jose, CA
2014-2020, Adjust Professor, Obstetrics and Gynecology, University of Pittsburgh, Pittsburgh, PA

Awards & Memberships

Awards

2013, ASCO Conquer Cancer Foundation Merit Award
2013, SGO MySGO Community Leadership Award

Memberships

Society of Gynecologic Oncology
American College of Obstetricians and Gynecologists
American Society of Clinical Oncology
California Medical Association, Santa Clara County Medical Association

Publications

Lin JF, et al. “Ovarian cancer patients selected for neoadjuvant chemotherapy vs. primary debulking surgery are not similar - A national cancer data base study.” Gynecol Oncol 2014; 135(2).
Gill BS, Lin JF, Krivak TC, et al. "National Cancer Data Base Analysis of Radiation Therapy Consolidation Modality for Cervical Cancer: The Impact of New Technological Advancements." Int J Radiat Oncol Biol Phys 2014.
Laskey RA, Richard SD, Smith AL, Lin JF, et al. “Retreatment with bevacizumab in patients with gynecologic malignancy is associated with clinical response and does not increase morbidity.” Onco Targets Ther 2014;7:469-76.
Yu MC, Austin RM, Lin JF, et al. “The diagnostic utility of HR-HPV as a predictor of cervical cancer recurrence.” Gynecol Oncol 2014; 133:64.
Laskey RA, Lin JF, et al. "The impact of concurrent chemoradiation on survival compared to adjuvant radiation therapy alone in patients with node-positive vulvar cancer." Gynecol Oncol 2014; 133:192-193.
Lin JF, et al. “Role of chemosensitization in elderly vaginal cancer patients: A National Cancer Data Base (NCDB) study.” Gynecol Oncol 2014; 133:173.
Lin JF, et al. "Definitive therapy for clinical stage I endometrial cancer in the elderly: A National Cancer Database study." Gynecol Oncol 2014; 133:171-172.
Boisen MM, Lin JF, et al. "Does the order of surgery and radiation therapy matter in the treatment of stage II endometrial cancer?" Gynecol Oncol 2014; 133:138-139.
Dickson EL, Lin JF, et al. “Gynecologic oncology fellow perspectives on research and career development symposia: A Gynecologic Oncology Fellows' and Allied Health Professionals' Research Network (GOFRN) survey study.” Gynecol Oncol 2014; 133:76-77.
Laskey RA, Ross MS, Lin JF, et al. “The role of adjuvant radiation and chemoradiation in single node-positive vulvar cancer.” Gynecol Oncol 2014; 133:36-37.
Lin JF, et al. "Characteristics of high-volume gynecologic cancer centers — framework toward centers of excellence: A National Cancer Data Base (NCDB) study." Gynecol Oncol 2014; 133:36.
Xu M, Rajagopalan MS, Lin J, et al. “Trends in the Utilization of Brachytherapy Boost in Vaginal Cancer in the United States.” Brachytherapy 2014; 13:S16
Lin JF, et al. “Impact of facility volume on therapy and survival for locally advanced cervical cancer.” Gynecol Oncol 2014;132(2):416-22.
Desai PH, Lin JF, Slomovitz BM. Milestones to optimal adoption of robotic technology in gynecology. Obstet Gynecol 2014;123(1):13-20.
Lin JF, et al., “Learning curve analysis of first 100 robotic assisted laparoscopic hysterectomies using a novel approach.” Int. J Gynecol Obstet. 2014;124(1):88-91.
Lin J, et al. “Comparison of primary surgery versus definitive radiation for treatment of early endometrial cancer in the elderly population.” Gynecol Oncol. 2012;127(1 Suppl): S13.
Lin JF, Slomovitz BM. Uterine Sarcoma 2008. Curr Oncol Rep. 2008;10(6):512-8.
Sharma S, … Lin J, et al. “Cyclooxygenase 2 inhibition promotes IFN-gamma-dependent enhancement of antitumor responses.” J Immunol. 2005;175(2):813-9.
Sharma S, … Lin JF et al. “SLC/CCL21-mediated anti-tumor responses require IFNgamma, MIG/CXCL9 and IP-10/CXCL10.” Mol Cancer 2003;2:22.
Sharma S, … Lin JF, et al. “Tumor cyclooxygenase 2-dependent suppression of dendritic cell function.” Clin Cancer Res 2003;9(3):961-8.

Ratings & Reviews

Ratings and reviews below are gathered from the Press Ganey Clinician and Group Consumer Assessment of Healthcare Providers and Systems (CG CAHPS) survey. CG CAHPS is a standardized survey that is used to measure a patient's experience in the physician office setting. Ratings are an average of all responses to questions about a provider's care, with five stars being the highest.

Ratings

5.0

Show respect for what you say

5.0

Spend enough time with you

5.0

Provider explain in way you understand

5.0

Provider listen carefully to you

4.9

Know important info medical history

4.9

Rate provider 0-10

4.9

Recommend this provider office

Reviews

06/21/23

Dr. Lin was the best doctor/surgeon I could have asked for. He was very patient with me and listened to all of my questions and concerns. He always made me feel comfortable and ease. He was extremely professional and overall absolutely wonderful experience with him and his team. The level of care and knowledge he provided was excellent. I wish more doctors were like him. :) - Verified patient

06/21/23

I would highly recommend this company and team members. From the person who greeted me at the main entrance up to my doctor. All very professional and wonderful. - Verified patient

06/14/23

I cannot say enough about how thankful I am for Dr Lin. He is a true gem. - Verified patient

06/08/23

Good experience - Verified patient

06/08/23

Good experience - Verified patient